C122T (p.Cys122Thr) variant of DRD3 (Dopamine receptor D3)
C122T (p.Cys122Thr) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes structural context.
C122T (p.Cys122Thr) variant details
- p.Cys122Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.858
- REVEL 0.88
- MetaLR 0.77
- MetaSVM 0.82
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available